For patients with diabetes, semaglutide use is associated with an increased risk for nonarteritic anterior ischemic optic ...

Novo Nordisk is preparing to launch its blockbuster obesity drug Wegovy (injectable semaglutide) in India later this year, the company told Business Today, setting the stage for a high-stakes battle ...

GLP-1 receptor agonist prescriptions increased significantly during study period across all categories of BMI, in dose-response manner.

Weight loss drugs like Ozempic gained popularity for managing obesity, diabetes, and related chronic conditions, a new study ...

While it is understood that the drugs have also proven to be safe and effective for thousands, the negative issues have led ...

UK: A systematic review and meta-analysis of randomized trials have highlighted the significant benefits of long-acting ...

Dr. Daniel Drucker, an endocrinologist and a clinician-scientist at the University of Toronto and the Lunenfeld-Tanenbaum ...

As demand soared for weight-loss drugs, price signals worked.

The decision counters a proposal by the Biden Administration to reimburse beneficiaries for the weight-loss medications.

It’s all over the internet and maybe even in your own neighborhood: a celebrity, friend or neighbor who’s had sudden changes ...

Having already been hailed for their ability to aid weight loss and treat diabetes, GLP-1 drugs like Ozempic and Mounjaro ...

Advances recognized by science’s most lucrative awards include high-energy physics experiments and groundbreaking weight-loss ...